Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 1
1986 2
1988 2
1989 1
1990 1
1991 5
1992 1
1993 1
1994 2
1995 2
1996 2
1997 5
1998 6
1999 1
2000 3
2001 4
2002 4
2003 2
2004 7
2005 3
2006 6
2007 5
2008 9
2009 7
2010 6
2011 4
2012 9
2013 14
2014 10
2015 11
2016 10
2017 11
2018 18
2019 11
2020 11
2021 18
2022 21
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Spinal muscular atrophy.
D'Amico A, Mercuri E, Tiziano FD, Bertini E. D'Amico A, et al. Orphanet J Rare Dis. 2011 Nov 2;6:71. doi: 10.1186/1750-1172-6-71. Orphanet J Rare Dis. 2011. PMID: 22047105 Free PMC article. Review.
The role of follow-up coordination has to be managed by an expert in neuromuscular disorders and in SMA who is able to plan a multidisciplinary intervention that includes pulmonary, gastroenterology/nutrition, and orthopedic care. Prognosis depends on the phenotypic severi …
The role of follow-up coordination has to be managed by an expert in neuromuscular disorders and in SMA who is able to plan a multidisciplin …
An overview of polymyositis and dermatomyositis.
Findlay AR, Goyal NA, Mozaffar T. Findlay AR, et al. Muscle Nerve. 2015 May;51(5):638-56. doi: 10.1002/mus.24566. Muscle Nerve. 2015. PMID: 25641317 Review.
Polymyositis and dermatomyositis are inflammatory myopathies that differ in their clinical features, histopathology, response to treatment, and prognosis. Although their clinical pictures differ, they both present with symmetrical, proximal muscle weakness. ...In this revi …
Polymyositis and dermatomyositis are inflammatory myopathies that differ in their clinical features, histopathology, response to treatment, …
Respiratory management of children with spinal muscular atrophy (SMA).
Fauroux B, Griffon L, Amaddeo A, Stremler N, Mazenq J, Khirani S, Baravalle-Einaudi M. Fauroux B, et al. Arch Pediatr. 2020 Dec;27(7S):7S29-7S34. doi: 10.1016/S0929-693X(20)30274-8. Arch Pediatr. 2020. PMID: 33357594 Review.
Training for patients and caregivers in cough-assisted techniques is recommended when respiratory muscle strength falls below 50% of predicted or in case of recurrent or severe respiratory infections. ...
Training for patients and caregivers in cough-assisted techniques is recommended when respiratory muscle strength falls below 50% of pred …
Dermatomyositis.
Callen JP, Wortmann RL. Callen JP, et al. Clin Dermatol. 2006 Sep-Oct;24(5):363-73. doi: 10.1016/j.clindermatol.2006.07.001. Clin Dermatol. 2006. PMID: 16966018 Review.
Autoimmune muscle disease.
Mammen A. Mammen A. Handb Clin Neurol. 2016;133:467-84. doi: 10.1016/B978-0-444-63432-0.00025-6. Handb Clin Neurol. 2016. PMID: 27112692 Review.
While most IBM patients do have autoantibodies, treatment with immunosuppressive agents does not improve their clinical course. Along with the presence of abnormally aggregated proteins on muscle biopsy, the refractory nature and relentless course of IBM suggest tha …
While most IBM patients do have autoantibodies, treatment with immunosuppressive agents does not improve their clinical course. Along …
Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.
Xu L, You H, Wang L, Lv C, Yuan F, Li J, Wu M, Da Z, Wei H, Yan W, Zhou L, Yin S, Zhou D, Wu J, Lu Y, Su D, Liu Z, Liu L, Ma L, Xu X, Zang Y, Liu H, Ren T, Wang F, Du Y, Xue J, Zhang M, Tan W. Xu L, et al. Arthritis Rheumatol. 2023 Apr;75(4):609-619. doi: 10.1002/art.42308. Epub 2023 Mar 17. Arthritis Rheumatol. 2023. PMID: 35849805
This study aimed to identify distinct phenotype groups in patients with anti-MDA5+ DM and to determine the utility of these phenotypes in predicting patient outcomes. METHODS: A total of 265 patients with anti-MDA5+ DM were retrospectively enrolled in the study. ...Classif …
This study aimed to identify distinct phenotype groups in patients with anti-MDA5+ DM and to determine the utility of these phenotypes in …
Endocrine neuromyopathies.
Anagnos A, Ruff RL, Kaminski HJ. Anagnos A, et al. Neurol Clin. 1997 Aug;15(3):673-96. doi: 10.1016/s0733-8619(05)70339-x. Neurol Clin. 1997. PMID: 9227958 Review.
Lambert-Eaton myasthenic syndrome.
Lipka AF, Verschuuren JJGM. Lipka AF, et al. Handb Clin Neurol. 2024;200:307-325. doi: 10.1016/B978-0-12-823912-4.00012-8. Handb Clin Neurol. 2024. PMID: 38494285 Review.
Rapid diagnosis is important because of the association with SCLC in 50%-60% of patients, which stresses the need for vigorous tumor screening after diagnosis. Clinical parameters can predict tumor probability and guide frequency of tumor screening. ...
Rapid diagnosis is important because of the association with SCLC in 50%-60% of patients, which stresses the need for vigorous tumor screeni …
Sarcoglycanopathies.
Kirschner J, Lochmüller H. Kirschner J, et al. Handb Clin Neurol. 2011;101:41-6. doi: 10.1016/B978-0-08-045031-5.00003-7. Handb Clin Neurol. 2011. PMID: 21496623 Review.
The clinical phenotype associated with sarcoglycanopathies is characterized by a slowly progressive proximal muscle weakness with onset during childhood in most cases. The disease course is often similar but more variable than X-linked Duchenne muscular dystrophy. ...
The clinical phenotype associated with sarcoglycanopathies is characterized by a slowly progressive proximal muscle weakness with onset duri …
Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.
Ruiz-Lozano RE, Velazquez-Valenzuela F, Roman-Zamudio M, Andrade-Leal SK, Rodriguez-Garcia A. Ruiz-Lozano RE, et al. Rheumatol Int. 2022 Jul;42(7):1119-1131. doi: 10.1007/s00296-021-05035-7. Epub 2021 Oct 21. Rheumatol Int. 2022. PMID: 34674015 Review.
However, other clinical features, systemic involvement, histopathological findings, response to treatment, and prognosis, differ significantly. Although uncommon, ocular manifestations in DM and PM may potentially affect any structure within the eye. ...
However, other clinical features, systemic involvement, histopathological findings, response to treatment, and prognosis, differ sign …
219 results